Original language | English |
---|---|
Pages (from-to) | 82-84 |
Number of pages | 3 |
Journal | Clinical Biochemistry |
Volume | 96 |
DOIs |
|
Publication status | Published - 1 Oct 2021 |
Bibliographical note
Funding Information:This research was funded by the Dutch Kidney Foundation (grant No. 17OI03). The Dutch Kidney Foundation is a non-profit organization which subsidizes research and innovation in nephrology and renal transplantation care.
Funding Information:
D.A. Hesselink has received lecture and consulting fees from Astellas Pharma, Chiesi Farmaceutici SpA and Novartis Pharma, as well as grant support from Astellas Pharma and Chiesi Farmaceutici SpA (paid to his institution).